A20 gene expression is regulated by TNF, Vitamin D and androgen in prostate cancer cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 94, Issue 1-3 SPEC. ISS., 2005, Pages 197-202

  Golovko, Olga ^a   Nazarova, Nadja ^a   Tuohimaa, Pentti ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Androgen; Gene expression; Prostate cancer; Vitamin D; Zinc finger protein A20

Indexed keywords

ANDROGEN; ANDROSTANOLONE; CALCITRIOL; MESSENGER RNA; TUMOR NECROSIS FACTOR; VITAMIN D;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER RESISTANCE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROSTATE; PROSTATE CARCINOMA; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 18144377023     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2005.01.019     Document Type: Article

References (31)

1. V.M. Dixit, S. Green, V. Sarma, L.B. Holzman, F.W. Wolf, K. O'Rourke, P.A. Ward, E.V. Prochownik, and R.M. Marks Tumor necrosis factor-alpha induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin J. Biol. Chem. 265 1990 2973 2978
2. A.W. Opipari Jr., M.S. Boguski, and V.M. Dixit The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein J. Biol. Chem. 265 1990 14705 14708
3. C.D. Laherty, N.D. Perkins, and V.M. Dixit Human T cell leukemia virus type I Tax and phorbol 12-myristate 13-acetate induce expression of the A20 zinc finger protein by distinct mechanisms involving nuclear factor kappa B J. Biol. Chem. 268 1993 5032 5039
4. C.D. Laherty, H.M. Hu, A.W. Opipari, F. Wang, and V.M. Dixit The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B J. Biol. Chem. 267 1992 24157 24160
5. V. Sarma, Z. Lin, L. Clark, B.M. Rust, M. Tewari, R.J. Noelle, and V.M. Dixit Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis J. Biol. Chem. 270 1995 12343 12346
6. M. Jaattela, H. Mouritzen, F. Elling, and L. Bastholm A20 zinc finger protein inhibits TNF and IL-1 signaling J. Immunol. 156 1996 1166 1173
7. K.L. He, and A.T. Ting A20 inhibits tumor necrosis factor (TNF) alpha-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor 1 complex in Jurkat T cells Mol. Cell. Biol. 22 2002 6034 6045
8. P. Tuohimaa, A. Lyakhovich, N. Aksenov, P. Pennanen, H. Syvala, Y.R. Lou, M. Ahonen, T. Hasan, P. Pasanen, M. Blauer, T. Manninen, S. Miettinen, P. Vilja, and T. Ylikomi Vitamin D and prostate cancer J. Steroid Biochem. Mol. Biol. 76 2001 125 134
9. C.M. Hansen, L. Binderup, K.J. Hamberg, and C. Carlberg Vitamin D and cancer: effects of 1,25(OH)2D3 and its analogs on growth control and tumorigenesis Front Biosci. 6 2001 D820 D848
10. T. Ylikomi, I. Laaksi, Y.R. Lou, P. Martikainen, S. Miettinen, P. Pennanen, S. Purmonen, H. Syvala, A. Vienonen, and P. Tuohimaa Antiproliferative action of vitamin D Vitam. Horm. 64 2002 357 406
11. L.V. Stewart, and N.L. Weigel Vitamin D and prostate cancer Exp. Biol. Med. (Maywood) 229 2004 277 284
12. S.H. Zhuang, and K.L. Burnstein Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation Endocrinology 139 1998 1197 1207
13. S.E. Blutt, T.J. McDonnell, T.C. Polek, and N.L. Weigel Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2 Endocrinology 141 2000 10 17
14. D. Rocker, A. Ravid, U.A. Liberman, O. Garach-Jehoshua, and R. Koren 1,25-Dihydroxyvitamin D3 potentiates the cytotoxic effect of TNF on human breast cancer cells Mol. Cell. Endocrinol. 106 1994 157 162
15. I.S. Mathiasen, C.M. Hansen, L. Foghsgaard, and M. Jaattela Sensitization to TNF-induced apoptosis by 1,25-dihydroxy vitamin D(3) involves up-regulation of the TNF receptor 1 and cathepsin B Int. J. Cancer 93 2001 224 231
16. R. Yacobi, R. Koren, U.A. Liberman, C. Rotem, L. Wasserman, and A. Ravid 1,25-dihydroxyvitamin D3 increases the sensitivity of human renal carcinoma cells to tumor necrosis factor alpha but not to interferon alpha or lymphokine-activated killer cells J. Endocrinol. 149 1996 327 333
17. J.M. Kokontis, N. Hay, and S. Liao Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest Mol. Endocrinol. 12 1998 941 953
18. L.G. Wang, L. Ossowski, and A.C. Ferrari Overexpressed androgen receptor linked to p21WAF1 silencing may be responsible for androgen independence and resistance to apoptosis of a prostate cancer cell line Cancer Res. 61 2001 7544 7551
19. B. Lytton Prostate cancer: a brief history and the discovery of hormonal ablation treatment J. Urol. 165 2001 1859 1862
20. A. Ashkenazi, and V.M. Dixit Death receptors: signaling and modulation Science 281 1998 1305 1308
21. D. Wallach Cytotoxins (tumour necrosis factor, lymphotoxin and others): molecular and functional characteristics and interactions with interferons Interferon 7 1986 89 124
22. D. Wissing, H. Mouritzen, and M. Jaattela TNF-induced mitochondrial changes and activation of apoptotic proteases are inhibited by A20 Free Radic. Biol. Med. 25 1998 57 65
23. R. Beyaert, K. Heyninck, and S. Van Huffel A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis Biochem. Pharmacol. 60 2000 1143 1151
24. A. Krikos, C.D. Laherty, and V.M. Dixit Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements J. Biol. Chem. 267 1992 17971 17976
25. H. Harant, B. Wolff, and I.J. Lindley 1Alpha,25-dihydroxyvitamin D3 decreases DNA binding of nuclear factor-kappaB in human fibroblasts FEBS Lett. 436 1998 329 334
26. D.M. Berry, C.S. Clark, and K.A. Meckling-Gill 1alpha,25-dihydroxyvitamin D3 stimulates phosphorylation of IkappaBalpha and synergizes with TPA to induce nuclear translocation of NFkappaB during monocytic differentiation of NB4 leukemia cells Exp. Cell. Res. 272 2002 176 184
27. S.H. Kim, S.N. Kang, H.J. Kim, and T.S. Kim Potentiation of 1,25-dihydroxyvitamin D(3)-induced differentiation of human promyelocytic leukemia cells into monocytes by costunolide, a germacranolide sesquiterpene lactone Biochem. Pharmacol. 64 2002 1233 1242
28. S.N. Kang, S.H. Kim, S.W. Chung, M.H. Lee, H.J. Kim, and T.S. Kim Enhancement of 1 alpha,25-dihydroxyvitamin D(3)-induced differentiation of human leukaemia HL-60 cells into monocytes by parthenolide via inhibition of NF-kappa B activity Br. J. Pharmacol. 135 2002 1235 1244
29. F. Galbiati, L. Polastri, B. Thorens, P. Dupraz, P. Fiorina, U. Cavallaro, G. Christofori, and A.M. Davalli Molecular pathways involved in the antineoplastic effects of calcitriol on insulinoma cells Endocrinology 144 2003 1832 1841
30. R.J. Skowronski, D.M. Peehl, and D. Feldman Vitamin D and prostate cancer: 1, 25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines Endocrinology 132 1993 1952 1960
31. T.C. Polek, L.V. Stewart, E.J. Ryu, M.B. Cohen, E.A. Allegretto, and N.L. Weigel p53 Is required for 1,25-dihydroxyvitamin D3-induced G0 arrest but is not required for G1 accumulation or apoptosis of LNCaP prostate cancer cells Endocrinology 144 2003 50 60